HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Development of Heterobivalent Theranostic Probes Having High Affinity/Selectivity for the GRPR/PSMA.

Abstract
In this study, we describe the development of heterobivalent [DUPA-6-Ahx-([111In]In-DO3A)-8-Aoc-BBN ANT] and [DUPA-6-Ahx-([177Lu]Lu-DO3A)-8-Aoc-BBN ANT] radiotracers that display very high selectivity/specificity for gastrin-releasing peptide receptor (GRPR)-/prostate-specific membrane antigen (PSMA)-expressing cells. These studies include metallation, purification, characterization, and in vitro and in vivo evaluation of the new small-molecule-/peptide-based radiopharmaceuticals having utility for imaging and potentially therapy. Competitive displacement binding assays using PC-3 cells and LNCaP cell membranes showed high binding affinity for the GRPR or the PSMA. Biodistribution studies showed favorable excretion pharmacokinetics with high tumor uptake in PC-3 or PC-3 prostatic inhibin peptide (PIP) tumor-bearing mice. For example, tumor accumulation at the 1 h time point ranged from (4.74 ± 0.90) to (7.51 ± 2.61)%ID/g. Micro-single-photon emission computed tomography (microSPECT) molecular imaging investigations showed very high uptake in tumors with minimal accumulation of tracers in the surrounding collateral tissues in xenografted mice at 4 h postintravenous injection. In conclusion, [DUPA-6-Ahx-([111In]In-DO3A)-8-Aoc-BBN ANT] and [DUPA-6-Ahx-([177Lu]Lu-DO3A)-8-Aoc-BBN ANT] tracers displayed favorable pharmacokinetic and excretion profiles with high uptake and retention in tumors.
AuthorsRajendra P Bandari, Terry L Carmack, Anil Malhotra, Lisa Watkinson, Emily A Fergason Cantrell, Michael R Lewis, Charles J Smith
JournalJournal of medicinal chemistry (J Med Chem) Vol. 64 Issue 4 Pg. 2151-2166 (02 25 2021) ISSN: 1520-4804 [Electronic] United States
PMID33534560 (Publication Type: Journal Article, Research Support, U.S. Gov't, Non-P.H.S.)
Chemical References
  • Antigens, Surface
  • Coordination Complexes
  • Fluorescent Dyes
  • Indium Radioisotopes
  • Membrane Glycoproteins
  • Oligopeptides
  • Radioisotopes
  • Radiopharmaceuticals
  • Receptors, Bombesin
  • Lutetium
  • Lutetium-177
  • Indium-111
  • FOLH1 protein, human
  • Glutamate Carboxypeptidase II
  • PSMA protein, mouse
Topics
  • Animals
  • Antigens, Surface (metabolism)
  • Cell Line, Tumor
  • Coordination Complexes (pharmacokinetics, pharmacology)
  • Fluorescent Dyes (pharmacokinetics, pharmacology)
  • Glutamate Carboxypeptidase II (metabolism)
  • Humans
  • Indium Radioisotopes (chemistry)
  • Lutetium (chemistry)
  • Male
  • Membrane Glycoproteins (metabolism)
  • Mice
  • Oligopeptides (pharmacokinetics, pharmacology)
  • Precision Medicine (methods)
  • Radioisotopes (chemistry)
  • Radiopharmaceuticals (pharmacokinetics, pharmacology)
  • Receptors, Bombesin (metabolism)
  • Tissue Distribution
  • Tomography, Emission-Computed, Single-Photon

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: